Reproductive Technology in Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorders (ARTiMS)
Type of Study/Intervention
Form of MS
The purpose of this study is to improve the quality of care that women with Multiple Sclerosis (MS) or Neuromyelitis Optica Spectrum Disorder (NMOSD) receive while using Assisted Reproductive Technology (ART).
We’re inviting women with MS or NMOSD who have already used ART to take part in surveys and interviews to discuss if and where they felt there were gaps in their pregnancy planning and fertility treatment care.
What will study participants be asked to do?
Participating in this study involves:
– A short survey
– A phone call discussion with one of our research nurses (if eligible)
– Group discussion (optional)
If you agree to take part in this study, you will be asked to complete a short survey that asks about your pregnancy history and some information about yourself.
Once that survey is complete, and if you agree, the nurse will contact you via phone or teleconference (such as Zoom or Microsoft Teams) to discuss your feelings about your journey with pregnancy and fertility.
The phone call will be a 20–60-minute conversation where you will be invited to discuss your feelings about your care.
During this phone call, you will also be asked to discuss:
– Where you looked for information about MS/NMOSD and pregnancy, what you found and if it was useful to you
– Gaps in the care or knowledge you received
– What could be done better in the future from healthcare professionals
There will also be an option to attend an in-person group discussion
These discussions will be with 6-8 other women who have also have MS or MNSOD and have required assistance to fall pregnant. These discussions will be limited to 1 hour, but may be much shorter, depending on how much everyone wants to discuss.
– Have been diagnosed with MS/NMOSD prior to attempting pregnancy through ART
– Were aged 18 or older at the time of ART attempt
– Are willing to discuss their pregnancy journey (including miscarriages and failed cycles) with a nurse
– Are willing to provide 12 months follow-up medical history if they do not participate in MSBase.
– Women who are not willing to provide details of their ART use and pregnancy history.
– Women who used ART before they were diagnosed with MS.
Anticipated start date
Susan Agland: firstname.lastname@example.org
Vicki Maltby email@example.com